Related Experiment Videos
Effects of prostaglandin E2 on mesangial cell migration
S Jaffer1, J Mattana, P C Singhal
1Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, N.Y. 11042, USA.
American Journal of Nephrology
|January 1, 1995
Summary
Prostaglandin E2 (PGE2) directly enhances mesangial cell migration, a key factor in kidney diseases. Cyclo-oxygenase inhibitors, like meclofenamate, reduce this migration, supporting their use in treating mesangiocapillary glomerulonephritis.
Area of Science:
- Nephrology
- Cell Biology
- Pharmacology
Background:
- Mesangial cell migration is implicated in renal diseases like mesangiocapillary glomerulonephritis.
- Cyclo-oxygenase inhibitors are a known treatment for this condition.
Purpose of the Study:
- To investigate the direct effect of prostaglandin E2 (PGE2) on mesangial cell migration.
- To explore the role of basal PGE2 production in mesangial cell migration.
Main Methods:
- Mesangial cells were treated with PGE2 and cyclo-oxygenase inhibitor meclofenamate.
- Cell migration was quantified by measuring the percentage of migrated area over 24 and 48 hours.
- The effect of phosphodiesterase inhibitor IBMX on cell migration was also assessed.
Main Results:
- PGE2 significantly increased mesangial cell migration at both 24 and 48 hours.
- Meclofenamate significantly inhibited mesangial cell migration, indicating basal PGE2 contributes to migration.
- IBMX also significantly enhanced mesangial cell migration.
Conclusions:
- Mesangial cell migration is directly promoted by PGE2.
- The findings provide a scientific basis for using cyclo-oxygenase inhibitors in treating mesangiocapillary glomerulonephritis.